Article info
PDFCase report
Hepatitis C during disease modifying therapy with Fingolimod for Relapsing Remitting Multiple Sclerosis: diagnosis and treatment
- Correspondence to Dr Aram Aslanyan; aram.aslanyan{at}doctors.org.uk
Citation
Hepatitis C during disease modifying therapy with Fingolimod for Relapsing Remitting Multiple Sclerosis: diagnosis and treatment
Publication history
- Accepted February 4, 2021
- First published February 26, 2021.
Online issue publication
January 24, 2024
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.